Sarepta Therapeutics, Inc. ( SRPT) - Key Metrics
SRPT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $3.81 | -$0.05 | -$0.05 | -$0.08 |
| 2026Q1 | $6.96 | $3.15 | -$1.93 | -$1.96 |
| 2025Q4 | $4.23 | -$2.70 | $1.25 | $1.20 |
| 2025Q3 | $3.98 | -$1.80 | -$0.15 | -$0.43 |
| 2025Q2 | $6.24 | $2.01 | $2.67 | $2.34 |
SRPT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -89.85 |
| 2026Q1 | 0% | 1.73 |
| 2025Q4 | 0% | -1.96 |
| 2025Q3 | 0% | -2.68 |
| 2025Q2 | 0% | 2.13 |
SRPT
Price: $17.65
52 week price:
Earnings Per Share: -1.61 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 366531
Ebitda: -43.3 millionMarket Capitalization: 1.8 billion